The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Minimal Residual Disease (MRD) Dynamic Monitor market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Minimal Residual Disease (MRD) Dynamic Monitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Minimal Residual Disease (MRD) Dynamic Monitor is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Minimal Residual Disease (MRD) Dynamic Monitor in Adjuvant Therapy Testing is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Minimal Residual Disease (MRD) Dynamic Monitor include BGI Genomics Co.,Ltd., OrigiMed, Burning Rock Biotech, Predicine, Genecast, 3D Medicines, Gene+, Geneseeq and Tongshu Biotechnology, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Blood Tumor MRD Dynamic Monitor, which accounted for % of the global market of Minimal Residual Disease (MRD) Dynamic Monitor in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Minimal Residual Disease (MRD) Dynamic Monitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimal Residual Disease (MRD) Dynamic Monitor.
The Minimal Residual Disease (MRD) Dynamic Monitor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Minimal Residual Disease (MRD) Dynamic Monitor market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Minimal Residual Disease (MRD) Dynamic Monitor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- BGI Genomics Co.,Ltd.
- OrigiMed
- Burning Rock Biotech
- Predicine
- Genecast
- 3D Medicines
- Gene+
- Geneseeq
- Tongshu Biotechnology
- Berry Oncology
Product Type Insights
Global markets are presented by Minimal Residual Disease (MRD) Dynamic Monitor type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Minimal Residual Disease (MRD) Dynamic Monitor are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Minimal Residual Disease (MRD) Dynamic Monitor segment by Type
- Blood Tumor MRD Dynamic Monitor
- Solid Ttumor MRD Dynamic Monitor
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Minimal Residual Disease (MRD) Dynamic Monitor market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Minimal Residual Disease (MRD) Dynamic Monitor market.
Minimal Residual Disease (MRD) Dynamic Monitor Segment by Application
- Adjuvant Therapy Testing
- Prognostic Assessment
- Postoperative Recurrence Detection
- Immunotherapy Efficacy Testing
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Minimal Residual Disease (MRD) Dynamic Monitor market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Minimal Residual Disease (MRD) Dynamic Monitor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Minimal Residual Disease (MRD) Dynamic Monitor and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Minimal Residual Disease (MRD) Dynamic Monitor industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Minimal Residual Disease (MRD) Dynamic Monitor.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Minimal Residual Disease (MRD) Dynamic Monitor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Blood Tumor MRD Dynamic Monitor
1.2.3 Solid Ttumor MRD Dynamic Monitor
1.3 Market by Application
1.3.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Adjuvant Therapy Testing
1.3.3 Prognostic Assessment
1.3.4 Postoperative Recurrence Detection
1.3.5 Immunotherapy Efficacy Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Perspective (2017-2028)
2.2 Minimal Residual Disease (MRD) Dynamic Monitor Growth Trends by Region
2.2.1 Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Minimal Residual Disease (MRD) Dynamic Monitor Historic Market Size by Region (2017-2022)
2.2.3 Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Region (2023-2028)
2.3 Minimal Residual Disease (MRD) Dynamic Monitor Market Dynamics
2.3.1 Minimal Residual Disease (MRD) Dynamic Monitor Industry Trends
2.3.2 Minimal Residual Disease (MRD) Dynamic Monitor Market Drivers
2.3.3 Minimal Residual Disease (MRD) Dynamic Monitor Market Challenges
2.3.4 Minimal Residual Disease (MRD) Dynamic Monitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Minimal Residual Disease (MRD) Dynamic Monitor Players by Revenue
3.1.1 Global Top Minimal Residual Disease (MRD) Dynamic Monitor Players by Revenue (2017-2022)
3.1.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue Market Share by Players (2017-2022)
3.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Minimal Residual Disease (MRD) Dynamic Monitor Revenue
3.4 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Concentration Ratio
3.4.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Minimal Residual Disease (MRD) Dynamic Monitor Revenue in 2021
3.5 Minimal Residual Disease (MRD) Dynamic Monitor Key Players Head office and Area Served
3.6 Key Players Minimal Residual Disease (MRD) Dynamic Monitor Product Solution and Service
3.7 Date of Enter into Minimal Residual Disease (MRD) Dynamic Monitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Minimal Residual Disease (MRD) Dynamic Monitor Breakdown Data by Type
4.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Historic Market Size by Type (2017-2022)
4.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Type (2023-2028)
5 Minimal Residual Disease (MRD) Dynamic Monitor Breakdown Data by Application
5.1 Global Minimal Residual Disease (MRD) Dynamic Monitor Historic Market Size by Application (2017-2022)
5.2 Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
6.2 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
6.3 North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
7.2 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
7.3 Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
8.2 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
8.3 Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
9.2 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
9.3 Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size (2017-2028)
10.2 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022)
10.3 Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BGI Genomics Co.,Ltd.
11.1.1 BGI Genomics Co.,Ltd. Company Detail
11.1.2 BGI Genomics Co.,Ltd. Business Overview
11.1.3 BGI Genomics Co.,Ltd. Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.1.4 BGI Genomics Co.,Ltd. Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.1.5 BGI Genomics Co.,Ltd. Recent Development
11.2 OrigiMed
11.2.1 OrigiMed Company Detail
11.2.2 OrigiMed Business Overview
11.2.3 OrigiMed Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.2.4 OrigiMed Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.2.5 OrigiMed Recent Development
11.3 Burning Rock Biotech
11.3.1 Burning Rock Biotech Company Detail
11.3.2 Burning Rock Biotech Business Overview
11.3.3 Burning Rock Biotech Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.3.4 Burning Rock Biotech Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.3.5 Burning Rock Biotech Recent Development
11.4 Predicine
11.4.1 Predicine Company Detail
11.4.2 Predicine Business Overview
11.4.3 Predicine Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.4.4 Predicine Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.4.5 Predicine Recent Development
11.5 Genecast
11.5.1 Genecast Company Detail
11.5.2 Genecast Business Overview
11.5.3 Genecast Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.5.4 Genecast Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.5.5 Genecast Recent Development
11.6 3D Medicines
11.6.1 3D Medicines Company Detail
11.6.2 3D Medicines Business Overview
11.6.3 3D Medicines Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.6.4 3D Medicines Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.6.5 3D Medicines Recent Development
11.7 Gene+
11.7.1 Gene+ Company Detail
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.7.4 Gene+ Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.7.5 Gene+ Recent Development
11.8 Geneseeq
11.8.1 Geneseeq Company Detail
11.8.2 Geneseeq Business Overview
11.8.3 Geneseeq Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.8.4 Geneseeq Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.8.5 Geneseeq Recent Development
11.9 Tongshu Biotechnology
11.9.1 Tongshu Biotechnology Company Detail
11.9.2 Tongshu Biotechnology Business Overview
11.9.3 Tongshu Biotechnology Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.9.4 Tongshu Biotechnology Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.9.5 Tongshu Biotechnology Recent Development
11.10 Berry Oncology
11.10.1 Berry Oncology Company Detail
11.10.2 Berry Oncology Business Overview
11.10.3 Berry Oncology Minimal Residual Disease (MRD) Dynamic Monitor Introduction
11.10.4 Berry Oncology Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
11.10.5 Berry Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Blood Tumor MRD Dynamic Monitor
Table 3. Key Players of Solid Ttumor MRD Dynamic Monitor
Table 4. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Region (2017-2022)
Table 8. Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Region (2023-2028)
Table 10. Minimal Residual Disease (MRD) Dynamic Monitor Market Trends
Table 11. Minimal Residual Disease (MRD) Dynamic Monitor Market Drivers
Table 12. Minimal Residual Disease (MRD) Dynamic Monitor Market Challenges
Table 13. Minimal Residual Disease (MRD) Dynamic Monitor Market Restraints
Table 14. Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Players (2017-2022)
Table 16. Global Top Minimal Residual Disease (MRD) Dynamic Monitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Dynamic Monitor as of 2021)
Table 17. Ranking of Global Top Minimal Residual Disease (MRD) Dynamic Monitor Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Minimal Residual Disease (MRD) Dynamic Monitor Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Minimal Residual Disease (MRD) Dynamic Monitor Product Solution and Service
Table 21. Date of Enter into Minimal Residual Disease (MRD) Dynamic Monitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue Market Share by Type (2017-2022)
Table 25. Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue Market Share by Type (2023-2028)
Table 27. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue Market Share by Application (2017-2022)
Table 29. Global Minimal Residual Disease (MRD) Dynamic Monitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Minimal Residual Disease (MRD) Dynamic Monitor Revenue Market Share by Application (2023-2028)
Table 31. North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size by Country (2023-2028) & (US$ Million)
Table 41. BGI Genomics Co.,Ltd. Company Detail
Table 42. BGI Genomics Co.,Ltd. Business Overview
Table 43. BGI Genomics Co.,Ltd. Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 44. BGI Genomics Co.,Ltd. Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 45. BGI Genomics Co.,Ltd. Recent Development
Table 46. OrigiMed Company Detail
Table 47. OrigiMed Business Overview
Table 48. OrigiMed Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 49. OrigiMed Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 50. OrigiMed Recent Development
Table 51. Burning Rock Biotech Company Detail
Table 52. Burning Rock Biotech Business Overview
Table 53. Burning Rock Biotech Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 54. Burning Rock Biotech Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 55. Burning Rock Biotech Recent Development
Table 56. Predicine Company Detail
Table 57. Predicine Business Overview
Table 58. Predicine Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 59. Predicine Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 60. Predicine Recent Development
Table 61. Genecast Company Detail
Table 62. Genecast Business Overview
Table 63. Genecast Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 64. Genecast Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 65. Genecast Recent Development
Table 66. 3D Medicines Company Detail
Table 67. 3D Medicines Business Overview
Table 68. 3D Medicines Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 69. 3D Medicines Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 70. 3D Medicines Recent Development
Table 71. Gene+ Company Detail
Table 72. Gene+ Business Overview
Table 73. Gene+ Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 74. Gene+ Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 75. Gene+ Recent Development
Table 76. Geneseeq Company Detail
Table 77. Geneseeq Business Overview
Table 78. Geneseeq Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 79. Geneseeq Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 80. Geneseeq Recent Development
Table 81. Tongshu Biotechnology Company Detail
Table 82. Tongshu Biotechnology Business Overview
Table 83. Tongshu Biotechnology Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 84. Tongshu Biotechnology Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 85. Tongshu Biotechnology Recent Development
Table 86. Berry Oncology Company Detail
Table 87. Berry Oncology Business Overview
Table 88. Berry Oncology Minimal Residual Disease (MRD) Dynamic Monitor Product
Table 89. Berry Oncology Revenue in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022) & (US$ Million)
Table 90. Berry Oncology Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Type: 2021 VS 2028
Figure 2. Blood Tumor MRD Dynamic Monitor Features
Figure 3. Solid Ttumor MRD Dynamic Monitor Features
Figure 4. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Application in 2021 & 2028
Figure 5. Adjuvant Therapy Testing Case Studies
Figure 6. Prognostic Assessment Case Studies
Figure 7. Postoperative Recurrence Detection Case Studies
Figure 8. Immunotherapy Efficacy Testing Case Studies
Figure 9. Others Case Studies
Figure 10. Minimal Residual Disease (MRD) Dynamic Monitor Report Years Considered
Figure 11. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Region: 2021 VS 2028
Figure 14. Global Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Players in 2021
Figure 15. Global Top Minimal Residual Disease (MRD) Dynamic Monitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Dynamic Monitor as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Minimal Residual Disease (MRD) Dynamic Monitor Revenue in 2021
Figure 17. North America Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Country (2017-2028)
Figure 19. United States Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Country (2017-2028)
Figure 23. Germany Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Region (2017-2028)
Figure 31. China Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Country (2017-2028)
Figure 39. Mexico Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Minimal Residual Disease (MRD) Dynamic Monitor Market Share by Country (2017-2028)
Figure 43. Turkey Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Minimal Residual Disease (MRD) Dynamic Monitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. BGI Genomics Co.,Ltd. Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 46. OrigiMed Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 47. Burning Rock Biotech Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 48. Predicine Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 49. Genecast Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 50. 3D Medicines Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 51. Gene+ Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 52. Geneseeq Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 53. Tongshu Biotechnology Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 54. Berry Oncology Revenue Growth Rate in Minimal Residual Disease (MRD) Dynamic Monitor Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
